Research graph
References from Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3892/ijo.2013.1887
10.3892/ijo.2013.1887 · External reference
Abstract 3157: p53 inactivation and STAT2 cooperate to enhance migration and metastasis of colon tumor cells
10.1158/1538-7445.am2018-3157 · 2018 · External reference
Podoplanin: an emerging cancer biomarker and therapeutic target
10.1111/cas.13580 · 2018 · External reference
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
10.1242/jcs.03218 · 2006 · External reference
Roles of podoplanin in malignant progression of tumor
10.3390/cells11030575 · 2022 · External reference
10.3389/fimmu.2012.00283
10.3389/fimmu.2012.00283 · External reference
Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells
10.1186/s12935-020-01328-2 · 2020 · External reference
Podoplanin‑positive cancer cells at the edge of esophageal squamous cell carcinomas are involved in invasion.
10.3892/mmr.2014.2338 · 2014 · External reference
10.1111/exd.14344
10.1111/exd.14344 · External reference
Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines
10.2334/josnusd.54.241 · 2012 · External reference
Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases
10.1186/s12885-018-5239-z · 2019 · External reference
10.1038/s41586-018-0206-z
10.1038/s41586-018-0206-z · External reference
The role of podoplanin in the biology of differentiated thyroid cancers
10.1371/journal.pone.0096541 · 2014 · External reference
Current therapeutic strategies in BRAF-mutant metastatic colorectal cancer
2021 · External reference
Novel inhibitor-based therapies for thyroid cancer-an update
10.3390/ijms222111829 · 2021 · External reference
10.3748/wjg.v21.i41.11673
10.3748/wjg.v21.i41.11673 · External reference
Upregulation of MAPK pathway is associated with survival in castrate-resistant prostate cancer
10.1038/bjc.2011.163 · 2011 · External reference
BRAF V600E mutation across multiple tumor types: correlation between DNA-based sequencing and mutation-specific immunohistochemistry
10.1097/pai.0000000000000516 · 2018 · External reference
Intracellular signal transduction and modification of the tumor microenvironment induced by RET/PTCs in papillary thyroid carcinoma
10.3389/fendo.2012.00067 · 2012 · External reference
RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma
2012 · External reference
BRAF mutation in thyroid cancer
10.1677/erc.1.0978 · 2005 · External reference
10.1002/cncr.29044
10.1002/cncr.29044 · External reference
High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma
10.1158/1078-0432.ccr-08-0933 · 2009 · External reference
Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
10.1186/s12957-016-0979-1 · 2016 · External reference
The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: a meta analysis
2015 · External reference
10.1001/jama.2013.3190
10.1001/jama.2013.3190 · External reference
BRAF mutation in papillary thyroid carcinoma: predictive value for long-term prognosis and radioiodine sensitivity
10.1016/j.anorl.2013.01.004 · 2014 · External reference
BRAF V600E mutation in papillary thyroid carcinoma: its relation to clinical features and oncologic outcomes in a single cancer centre experience
10.1530/ec-21-0410 · 2021 · External reference
Analysis of the role of FRMD5 in the biology of papillary thyroid carcinoma
10.3390/ijms22136726 · 2021 · External reference
10.1038/nmeth.2019
10.1038/nmeth.2019 · External reference
10.1186/s13059-014-0550-8
10.1186/s13059-014-0550-8 · External reference
10.1038/75556
10.1038/75556 · External reference
The reactome pathway knowledgebase 2022
2021 · External reference
10.3389/fgene.2019.00858
10.3389/fgene.2019.00858 · External reference
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
10.1186/1471-2105-12-35 · 2011 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
10.1158/0008-5472.can-07-6052
10.1158/0008-5472.can-07-6052 · External reference
10.1006/excr.2002.5630
10.1006/excr.2002.5630 · External reference
Novel mechanism of regulation of rac activity and lamellipodia formation by RET tyrosine kinase*
10.1074/jbc.m200643200 · 2002 · External reference
10.1016/s0092-8674(04)00215-6
10.1016/s0092-8674(04)00215-6 · External reference
10.1371/journal.pone.0036739
10.1371/journal.pone.0036739 · External reference
Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras–MEK–ERK pathway and of Thr69 through RalGDS–Src–p38
10.1093/emboj/cdf361 · 2002 · External reference
10.1074/jbc.m209799200
10.1074/jbc.m209799200 · External reference
10.1128/mcb.18.2.1065
10.1128/mcb.18.2.1065 · External reference
10.1073/pnas.95.21.12202
10.1073/pnas.95.21.12202 · External reference
ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation
10.1002/j.1460-2075.1995.tb07076.x · 1995 · External reference
10.1128/mcb.14.5.3283-3291.1994
10.1128/mcb.14.5.3283-3291.1994 · External reference
10.1074/jbc.m411161200
10.1074/jbc.m411161200 · External reference
10.1073/pnas.97.6.2462
10.1073/pnas.97.6.2462 · External reference
10.1016/j.mce.2017.12.003
10.1016/j.mce.2017.12.003 · External reference
10.1016/s1097-2765(04)00153-4
10.1016/s1097-2765(04)00153-4 · External reference
10.1186/1478-811x-8-23
10.1186/1478-811x-8-23 · External reference
10.1161/01.res.86.10.1019
10.1161/01.res.86.10.1019 · External reference
Podoplanin regulates the migration of mesenchymal stromal cells and their interaction with platelets
2019 · External reference
10.1016/j.brainres.2013.03.035
10.1016/j.brainres.2013.03.035 · External reference
10.1016/j.cell.2007.05.018
10.1016/j.cell.2007.05.018 · External reference
Unresolved reference
External reference
The roles of GTPase-activating proteins in regulated cell death and tumor immunity
10.1186/s13045-021-01184-1 · 2021 · External reference
P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac
10.1016/s0092-8674(02)00663-3 · 2002 · External reference
10.4161/21541248.2014.973770
10.4161/21541248.2014.973770 · External reference
The mTOR-RUNX1 pathway regulates DC-SIGN expression in renal tubular epithelial cells
10.1016/j.bbrc.2019.09.042 · 2019 · External reference
10.1038/ncomms13683
10.1038/ncomms13683 · External reference
10.1038/s41388-020-1318-0
10.1038/s41388-020-1318-0 · External reference
The mTOR-RUNX1 pathway regulates DC-SIGN expression in renal tubular epithelial cells
10.1016/j.bbrc.2019.09.042 · 2019 · External reference
10.1091/mbc.e02-08-0469
10.1091/mbc.e02-08-0469 · External reference
10.1038/nature09144
10.1038/nature09144 · External reference
Unresolved reference
External reference
The roles of SHANK1 in the development of colon cancer
10.1002/cbf.3529 · 2020 · External reference
Abl tyrosine kinases modulate cadherin-dependent adhesion upstream and downstream of Rho family GTPases
10.4161/cc.7.4.5452 · 2008 · External reference
c-Abl tyrosine kinase regulates neutrophil crawling behavior under fluid shear stress via Rac/PAK/LIMK/cofilin signaling axis
10.1002/jcb.26453 · 2018 · External reference
Unresolved reference
External reference
SRC-RAC1 signaling drives drug resistance to BRAF inhibition in de-differentiated cutaneous melanomas
10.1038/s41698-022-00310-7 · 2022 · External reference
